Diet for Liver Cancer Patients
Primary liver cancer from liver cell mutations is rare in the United States, according to the A.P. Johan Institute for Cancer Research. It is categorized based on the liver cells impacted, with the most prominent form starting in the hepatocytes, your main liver cells. The liver is also susceptible to cancer metastasized from other organs, but the cancer is generally named for the originating organ. Healthy diet plays a role in protecting the diseased liver from further damage, as well as keeping you nourished during cancer treatment.
If you are experiencing serious medical symptoms, seek emergency treatment immediately.
Lean Protein
Your liver acts as a nutrient filter to process waste products from food during digestion. Liver cancer can inhibit your liver from properly detoxifying foods, especially fatty forms of protein. To prevent waste buildup, choose lean forms of protein and limit your daily intake to give your liver time to metabolize the nutrient properly. Lean proteins include poultry, fish, beans, nuts and seeds. Dairy also supplies protein in your diet but opt for low or non-fat versions. Bake, broil, roast or grill meat proteins instead of frying. Avoid fatty red meats and processed meats like bacon or hot dogs.
- Your liver acts as a nutrient filter to process waste products from food during digestion.
Grains
Non-Hodgkin's Lymphoma Diet
Learn More
Grains like bread, pasta, rice or cereal are carbohydrates important for providing your body with glucose, an important source of energy for your cells. Depending on your stage of liver cancer and treatment process, you may need to alternate your consumption of whole grains versus white grains. Whole grains like wheat bread, bran cereal or brown rice are rich in fiber for digestion regulation and vitamins and minerals to protect your organs.
Fruits and Vegetables
Include several daily servings of fruits and vegetables as the foundation of your liver cancer diet 6. Fighting cancer cells depletes the body of essential vitamins and minerals. Fresh produce is power-packed with a variety of nutrients to replenish your system. Before, during and after cancer treatment consume an array of green vegetables like broccoli, spinach or Brussels sprouts, as well as plenty of carrots, sweet potatoes and squash. Choose colorful fruits like cantaloupe, citrus, apples or berries as snacks in between meals or side dishes.
- Include several daily servings of fruits and vegetables as the foundation of your liver cancer diet 6.
- Before, during and after cancer treatment consume an array of green vegetables like broccoli, spinach or Brussels sprouts, as well as plenty of carrots, sweet potatoes and squash.
Foods to Avoid
Foods Known to Damage the Liver
Learn More
Alcohol use is linked to several cancers including liver cancer, according to the American Cancer Society 156. Alcohol causes inflammation of your liver. The type of alcoholic beverage doesn't matter; all alcohol is perceived as a toxin to your liver. Too much sodium or table salt in your diet can promote swelling and fluid buildup. Consult your physician for dietary sodium limitations as part of your liver cancer diet. Avoid consumption of improperly stored foods including grains and nuts, which may contain a poisonous fungus called aflatoxin that harms the liver.
- Alcohol use is linked to several cancers including liver cancer, according to the American Cancer Society 1.
- Too much sodium or table salt in your diet can promote swelling and fluid buildup.
Related Articles
References
- American Cancer Society; Liver Cancer Overview; April 18, 2011
- Memorial Sloan-Kettering Cancer Center; Eating Well During and After Cancer Treatment; Diana Glauner, RD, CDN et al.; 2001
- Virginia Tech; The Diet and Cancer Connection; Kathleen M. Stadler; May 1, 2009
- MedlinePlus; Diet Liver Disease; April 23, 2009
- American Cancer Society: Types of Cancer Linked to Alcohol Use; Feb. 5, 2010
- American Liver Foundation: Liver Cancer
- Recio-Boiles A, Waheed A, Babiker HM. Cancer, Liver. [Updated 2019 Aug 4]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2020 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK448337/
- Musick SR, Smith M, Babiker HM. Cancer, Hepatoblastoma. [Updated 2020 Jan 13]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2020 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK534795/
- PDQ Adult Treatment Editorial Board. Adult Primary Liver Cancer Treatment (PDQ®): Health Professional Version. 2019 Oct 3. In: PDQ Cancer Information Summaries [Internet]. Bethesda (MD): National Cancer Institute (US); 2002-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK66030/
- Young M, John S. Hepatic Chemoembolization. [Updated 2019 Dec 15]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2020 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK507822/
- National Cancer Institute. Primary Liver Cancer Treatment (PDQ)—Health Professional Version. Updated -2/06/18. https://www.cancer.gov/types/liver/hp/adult-liver-treatment-pdq
- El-Serag HB. Epidemiology of viral hepatitis and hepatocellular carcinoma. Gastroenterology. 2012;142(6):1264‐1273.e1. doi:10.1053/j.gastro.2011.12.061
- Recio-Boiles A, Waheed A, Babiker HM. Cancer, Liver. [Updated 2019 Aug 4]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2020 Jan-.
- Trefts E, Gannon M, Wasserman DH. The liver. Curr Biol. 2017;27(21):R1147‐R1151. doi:10.1016/j.cub.2017.09.019
- Musick SR, Smith M, Babiker HM. Cancer, Hepatoblastoma. [Updated 2020 Jan 13]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2020 Jan-.
- Dimitroulis D, Damaskos C, Valsami S, et al. From diagnosis to treatment of hepatocellular carcinoma: An epidemic problem for both developed and developing world. World J Gastroenterol. 2017;23(29):5282‐5294. doi:10.3748/wjg.v23.i29.5282
- Suh JK, Lee J, Lee JH, Shin S, Tchoe HJ, Kwon JW. Risk factors for developing liver cancer in people with and without liver disease. PLoS One. 2018;13(10):e0206374. Published 2018 Oct 29. doi:10.1371/journal.pone.0206374
- Ringelhan M, McKeating JA, Protzer U. Viral hepatitis and liver cancer [published correction appears in Philos Trans R Soc Lond B Biol Sci. 2018 Jan 5;373(1737):]. Philos Trans R Soc Lond B Biol Sci. 2017;372(1732):20160274. doi:10.1098/rstb.2016.0274
- Matsushita H, Takaki A. Alcohol and hepatocellular carcinoma. BMJ Open Gastroenterol. 2019;6(1):e000260. Published 2019 Apr 3. doi:10.1136/bmjgast-2018-000260
- Reyes CV. Hepatocellular Carcinoma in Wilson Disease-related Liver Cirrhosis. Gastroenterol Hepatol (N Y). 2008;4(6):435‐437.
- Fung BM, Lindor KD, Tabibian JH. Cancer risk in primary sclerosing cholangitis: Epidemiology, prevention, and surveillance strategies. World J Gastroenterol. 2019;25(6):659‐671. doi:10.3748/wjg.v25.i6.659
- Liu Y, Wu F. Global burden of aflatoxin-induced hepatocellular carcinoma: a risk assessment. Environ Health Perspect. 2010;118(6):818‐824. doi:10.1289/ehp.0901388
- Volk ML, Marrero JA. Early detection of liver cancer: diagnosis and management. Curr Gastroenterol Rep. 2008;10(1):60‐66. doi:10.1007/s11894-008-0010-2
- Poynard T, Peta V, Deckmyn O, et al. LCR1 and LCR2, two multi-analyte blood tests to assess liver cancer risk in patients without or with cirrhosis. Aliment Pharmacol Ther. 2019;49(3):308‐320. doi:10.1111/apt.15082
- Oliva MR, Saini S. Liver cancer imaging: role of CT, MRI, US and PET. Cancer Imaging. 2004;4 Spec No A(Spec No A):S42‐S46. Published 2004 Apr 2. doi:10.1102/1470-7330.2004.0011
- Di Tommaso L, Spadaccini M, Donadon M, et al. Role of liver biopsy in hepatocellular carcinoma. World J Gastroenterol. 2019;25(40):6041‐6052. doi:10.3748/wjg.v25.i40.6041
- PDQ Adult Treatment Editorial Board. Adult Primary Liver Cancer Treatment (PDQ®): Health Professional Version. 2019 Oct 3. In: PDQ Cancer Information Summaries [Internet]. Bethesda (MD): National Cancer Institute (US); 2002-.
- Young M, John S. Hepatic Chemoembolization. [Updated 2019 Dec 15]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2020 Jan-.
- Gish RG, Finn RS, Marrero JA. Extending survival with the use of targeted therapy in the treatment of hepatocellular carcinoma. Gastroenterol Hepatol (N Y). 2013;9(4 Suppl 2):1‐24.
- Shi M, Guo RP, Lin XJ, et al. Partial hepatectomy with wide versus narrow resection margin for solitary hepatocellular carcinoma: a prospective randomized trial. Ann Surg. 2007;245(1):36‐43. doi:10.1097/01.sla.0000231758.07868.71
- Jadlowiec CC, Taner T. Liver transplantation: Current status and challenges. World J Gastroenterol. 2016;22(18):4438‐4445. doi:10.3748/wjg.v22.i18.4438
- Chen CP. Role of Radiotherapy in the Treatment of Hepatocellular Carcinoma. J Clin Transl Hepatol. 2019;7(2):183‐190. doi:10.14218/JCTH.2018.00060
- Izzo F, Granata V, Grassi R, et al. Radiofrequency Ablation and Microwave Ablation in Liver Tumors: An Update. Oncologist. 2019;24(10):e990‐e1005. doi:10.1634/theoncologist.2018-0337
- Noonan A, Pawlik TM. Hepatocellular carcinoma: an update on investigational drugs in phase I and II clinical trials. Expert Opin Investig Drugs. 2019;28(11):941‐949. doi:10.1080/13543784.2019.1677606
- Woodrell CD, Hansen L, Schiano TD, Goldstein NE. Palliative Care for People With Hepatocellular Carcinoma, and Specific Benefits for Older Adults. Clin Ther. 2018;40(4):512-525.
- Momin B, Millman AJ, Nielsen DB, Revels M, Steele CB. Promising practices for the prevention of liver cancer: a review of the literature and cancer plan activities in the National Comprehensive Cancer Control Program. Cancer Causes Control. 2018;29(12):1265‐1275. doi:10.1007/s10552-018-1094-0
- Momin BR, Pinheiro PS, Carreira H, Li C, Weir HK. Liver cancer survival in the United States by race and stage (2001-2009): Findings from the CONCORD-2 study. Cancer. 2017;123 Suppl 24(Suppl 24):5059‐5078. doi:10.1002/cncr.30820
- Domínguez-Cabello E, Martín-Rodríguez A, Pérez-San-Gregorio MA, Fernández-Jiménez E, Sousa-Martín JM, Bernardos-Rodríguez A. Coping strategies in liver patients as a function of relatives' anxiety level. Transplant Proc. 2012;44(9):2616‐2618. doi:10.1016/j.transproceed.2012.09.106
- Nguyen DL, Chao D, Ma G, Morgan T. Quality of life and factors predictive of burden among primary caregivers of chronic liver disease patients. Ann Gastroenterol. 2015;28(1):124‐129.
- Forner, A., Reig, M., and J. Bruix. Hepatocellular Carcinoma. Lancet. 2018 Jan 4. (Epub ahead of print).
- National Cancer Institute. Primary Liver Cancer Treatment (PDQ)—Health Professional Version. Updated -2/06/18.
- Woodrell, C., Hansen, L., Schiano, T., and N. Goldstein. Palliative Care for People With Hepatocellular Carcinoma, and Specific Benefits for Older Adults. Clinical Therapeutics. 2018 Mar 20. (Epub ahead of print).
Resources
Writer Bio
Aubri John has been a contributing researcher and writer to online physical and mental health oriented journals since 2005. John publishes online health and fitness articles that coincide with her licensed clinical skills in addictions, psychology and medical care. She has a master's degree in clinical social work and a Ph.D. in health psychology.